✦ LIBER ✦

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer

✍ Scribed by Charlotte L. Zuur; Yvonne J.W. Simis; Roxanna S. Verkaik; Jan H. Schornagel; Alfons J.M. Balm; Wouter A. Dreschler; Coen R.N. Rasch

Book ID: 118497201
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 88 KB
Volume: 89
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2008.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hearing loss due to low-dose cisplatin c

Hearing loss due to low-dose cisplatin chemoradiation head and neck cancer

✍ Charlotte Zuur 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Concurrent chemoradiation with daily low

Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma

✍ Frank J.P. Hoebers; Wilma Heemsbergen; Alfons J.M. Balm; Mathilde van Zanten; Ja 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 84 KB

703 poster Concurrent chemoradiation wit

703 poster Concurrent chemoradiation with daily low dose cisplatin in advanced stage head and neck cancer patients

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Toxicity of daily low dose cisplatin in

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer

✍ Hendrik Andreas Wolff; Tobias Overbeck; Ralph M. Roedel; Robert M. Hermann; Mark 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 258 KB

Efficacy of low-dose cisplatin-based che

Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer

✍ Xin-Biao Liao; Sen-Xiang Yan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Prognostic value of primary tumor volume

Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma

✍ Frank J. P. Hoebers; Frank A. Pameijer; Josien de Bois; Wilma Heemsbergen; Alfon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

## Abstract ## Background. The purpose of this study was to evaluate the prognostic value of tumor volume in head and neck squamous cell carcinoma treated with chemoradiation. ## Methods. Forty‐six patients were treated with radiotherapy and cisplatin (6 mg/m^2^ IV x20, daily). Baseline primary